Methenamine Mandelate Delayed-Release Tablets
» Methenamine Mandelate Delayed-Release Tablets contain not less than 95.0 percent and not more than 105.0 percent of the labeled amount of methenamine mandelate (C6H12N4·C8H8O3).
Packaging and storage—
Preserve in well-closed containers.
USP Reference standards 
11
—
11—
USP Methenamine Mandelate RS 
') + '&img=../../images/v35300/cas-587-23-5.gif',600,500);)
Disintegration 701:
2 hours and 30 minutes, determined as directed under Delayed-release (enteric coated) Tablets.
701:
2 hours and 30 minutes, determined as directed under Delayed-release (enteric coated) Tablets.
Other requirements—
Delayed-release Tablets respond to the Identification test and meet the requirements for Uniformity of dosage units and Assay under Methenamine Mandelate Tablets.
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
| Topic/Question | Contact | Expert Committee |
|---|---|---|
| Monograph | Leonel M. Santos, Ph.D.
Senior Scientific Liaison 1-301-816-8168 |
(SM12010) Monographs - Small Molecules 1 |
| Reference Standards | RS Technical Services 1-301-816-8129 rstech@usp.org |
|
| 701 |
Margareth R.C. Marques, Ph.D.
Senior Scientific Liaison 1-301-816-8106 |
(GCDF2010) General Chapters - Dosage Forms |
USP35–NF30 Page 3850